3,4-Methylenedioxyamphetamine

N-Methyl-3,4-methylenedioxyamphetamine

Deoxyepinephrine

Hallucinogens

Amphetamines

Substance Abuse Detection

Methamphetamine

Designer Drugs

Gas Chromatography-Mass Spectrometry

Serotonin Agents

Forensic Toxicology

Street Drugs

Amphetamine

Central Nervous System Stimulants

Spectrometry, Mass, Electrospray Ionization

Stereoisomerism

Chromatography, High Pressure Liquid

Reproducibility of Results

MMDA (drug)

DMMDA-2

Substituted phenethylamine

Methylenedioxybenzylamphetamine

ALPHA (psychedelic)

Indane

MDAT

NM-2-AI

MDAI

Methylenedioxyallylamphetamine

DMMDA

Methylenedioxybutylamphetamine

Methylenedioxydimethylamphetamine

Substituted methylenedioxyphenethylamine

DiFMDA

Pizotifen

6-Methyl-MDA

5-APDI

5-Methyl-MDA

2-Methyl-MDA

5-APDB

6-APDB

5-MAPDB

6-APT

Substituted benzofuran

6-MAPDB

5-MAPB

Alpha-Methyldopamine

MMDA-2

EDMA

Opium Law

3,4-Methylenedioxyamphetamine

Phenethylamine

Controlled Drugs and Substances Act

Harold Blauer

1,3-Benzodioxolylbutanamine

Bruxism

Edgewood Arsenal human experiments

3,4-Methylenedioxy-N-isopropylamphetamine

2,4,5-Trihydroxyamphetamine

Sass

Phenylacetones

PiHKAL

5-HT1A receptor

List of psychedelic drugs

MDA

2,3-Methylenedioxymethamphetamine

Serotonin releasing agent

MDMA15

• Administration of 1.5 mg/kg 3,4-methylenedioxymethamphetamine (MDMA), a recently restricted Schedule I drug, produced 100% MDE-appropriate responding in the MDE-trained rats and decreased discriminative performance was similarly observed following lower doses of MDMA (ED50 = 0.62 mg/kg). (erowid.org)
• The mechanism of 3,4-methylenedioxymethamphetamine (d-MDMA)-induced neurotoxicity may involve formation of toxic radical species. (nih.gov)
• The vitamin E-deficient group, treated with the low dose of d-MDMA, exhibited neurotoxic responses, including reduced striatal dopamine (47%) and elevated GFAP protein (3-fold): while the sufficient diet group was not altered. (nih.gov)
• This Phase 2, open-label, multi-site study will explore the safety and feasibility of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy and adjunctive caregiver involvement in the treatment of 18 participants with eating disorders. (clinicaltrials.gov)
• 3,4-methylenedioxymethamphetamine (MDMA) is a monoamine releaser and re-uptake inhibitor with indirect effects of neurohormone release. (clinicaltrials.gov)
• and 3,4-methylenedioxyamphetamine (MDA)/13,4-methylenedioxyethyl-amphetamine (MDEA)/3,4-methylenedioxymethamphetamine (MDMA). (medscape.com)
• In 1985, published reports stated that MDMA and its demethylated metabolite 3,4-methylenedioxyamphetamine (MDA) had long-term neurotoxic effects in laboratory animals. (medscape.com)
• Ecstasy, known scientifically as N-methyl-3,4-methylenedioxyamphetamine (MDMA), has the reputation of being a raver's drug of choice. (maps.org)
• However, the media have largely been referring to Ecstasy - the street name for this drug - as the treatment in this trial, rather than MDMA (3,4-methylenedioxymethamphetamine). (medicaldaily.com)
• Although administration of MDMA and its metabolite methylenedioxyamphetamine to rats produces serotonergic nerve terminal degeneration, these compounds are not neurotoxic when injected directly into the brain. (aspetjournals.org)
• MDMA (3,4-Methylenedioxy- N -methylamphetamine) , also known as ecstasy or molly, is a member of the group of phenethylamines. (chemistryviews.org)
• A detailed description is given of the development and validation of a fully automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry (SPE-LC-MS/MS) method capable of detecting 90 central-stimulating new psychoactive substances (NPS) and 5 conventional amphetamine-type stimulants (amphetamine, 3,4-methylenedioxy-methamphetamine (MDMA), 3,4-methylenedioxy-amphetamine (MDA), 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), methamphetamine) in serum. (uni-koeln.de)
• The popular recreational drug, 3,4-methylenedioxymethamphetamine (MDMA) exerts its actions in part via blockade of serotonin and dopamine reuptake. (ewha.ac.kr)
• Difluoromethylenedioxyamphetamine ( DiFMDA ) is a substituted derivative of 3,4-methylenedioxyamphetamine (MDA), which was developed by Daniel Trachsel and coworkers, along with the corresponding fluorinated derivatives of MDMA, MDEA, BDB and MBDB, with the aim of finding a non-neurotoxic drug able to be used as a less harmful substitute for entactogenic drugs such as MDMA . (cloudfront.net)
• MDA is 3,4-Methylenedioxyamphetamine while MDMA is 3,4-Methyl​enedioxy​methamphetamine. (healingmaps.com)

MMDA1

• MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a member of the amphetamine drug class with stimulant and psychedelic properties. (drugbank.com)

Amphetamine4

• 1) 3,4-methylenedioxy amphetamine. (naturalnews.com)
• 2) 5-methoxy-3,4-methylenedioxy amphetamine. (naturalnews.com)
• 3) 3,4,5-trimethoxy amphetamine. (naturalnews.com)
• It is usually sold in tablet form, frequently mixed with other psychoactive amphetamine derivates like MDA (3,4-methylenedioxyamphetamine), MBDB (2-methylamino-1-(3,4-methylenedioxyphenyl)butane), and MDE (3,4-methylenedioxy- N -ethylamphetamine), or other cutting agents like m -CPP ( meta -chlorophenylpiperazine) and PMA (4-methoxyamphetamine). (chemistryviews.org)

Trained to discriminate1

• Eight male rats were trained to discriminate 2.0 mg/kg N-ethyl-3,4-methylenedioxyamphetamine (MDE) from its vehicle using a two-lever, food-motivated operant discrimination task. (erowid.org)

Ecstasy1

• The experiment examines how 3,4-Methylenedioxymethamphetamine, better known as ecstasy, may alleviate the crippling, long-term horrors of "chronic, treatment-resistant, combat-related PTSD" when administered at low doses and in controlled settings. (maps.org)

Methamphetamine1

• 3) Any substance (except an injectable liquid) which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers. (procon.org)

19791

• 1979;15(4):405-9. (erowid.org)

Substance2

• 3) To possess a controlled substance. (ncleg.net)
• 4) A controlled substance classified in Schedule VI shall be guilty of a Class 3 misdemeanor, but any sentence of imprisonment imposed must be suspended and the judge may not require at the time of sentencing that the defendant serve a period of imprisonment as a special condition of probation. (ncleg.net)

Heroin1

• More recently, another class of compounds known as benzimidazole-opioids have begun appearing in cities across the country as adulterants in the heroin supply, adding a new threat to public health ( 3 ). (cdc.gov)

20171

• 4 Recent statistics from the International Diabetes Federation show that 425 million adults worldwide had diabetes in 2017. (xiahepublishing.com)

Lysergic1

• 4) Lysergic acid. (procon.org)

Drug1

• Drug and Alcohol Dependence , 72 (3), 225-235. (ewha.ac.kr)

Search1

• Compound identification with LC-MS usually involves accurate molecular mass measurements (8-14), multiple reaction monitoring (MRM) (15-19), and acquisition of tandem mass spectra with subsequent library search (3-7, 20-37). (spectroscopyonline.com)

Effects1

• The erroneous association is due to MDA, 3,4-methylenedioxyamphetamine, a close analogue studied for its antidepressive and appetite suppressant effects developed in 1949-1957 by Smith, Kline, and French. (medscape.com)

Full1

• The guidelines were fully achieved for 62 analytes (with a limit of detection (LOD) between 0.2 and 4 mu g/L), whilst full validation was not feasible for the remaining 12 analytes. (uni-koeln.de)

Analysis1

• We performed Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis of differentially expressed genes by the clusterProfiler R package (3.14.3). (biomedcentral.com)

Treatment1

• 4] While most improve with supportive treatment alone, the patient should be evaluated for signs of hyperthermia, dehydration, hyponatremia, seizures, hypertensive crises, cardiac dysrhythmias, and possible signs of serotonin syndrome. (medscape.com)